search IU Home 
PagesResearchTechnologyOutreachHeadlinersHealthArtsFACULTY and STAFF news from the campuses of Indiana University
 
Columns
Conversations
Viewpoint
Browser
Fast facts
Web
mastery
Knowledge Transfer
Photographer's corner


About 
Home Pages
Schedule
Contact
Archives
Awards

Home > Health >

IUSM physicians participate in autism treatment trials

Promising results from a multi-center trial for a medication for children with autism has been published in the New England Journal of Medicine. The IU School of Medicine's Department of Psychiatry was one of the five sites testing the drug, which is one of a newer class of anti-psychotic medications. Co-author of the article is Dr. Christopher McDougle, the Albert Eugene Sterne Professor of clinical psychiatry and chair of psychiatry at the IUSM.

The medication, risperidone, was successful and well tolerated for the treatment of serious behavioral disturbance associated with autistic disorder in children ages 5 to 17. The clinical trial is funded by the National Institute of Mental Health.
http://www.medicine.indiana.edu/news_releases/archive_02/autism.html

 
Indiana University
IU Home Pages
400 E. 7th Street. Bloomington, IN 47405
Phone: (812) 855-6494

Publication date: August 23, 2002
Comments: homepgs@indiana.edu
Copyright 2000, The Trustees of Indiana University